PSYSCAN
PSYSCAN is an international, multicenter study examining the early stages of psychosis. Between 2016 and 2019, the study recruited participants, aged between 14 and 40 years, from across Europe, North America, South America, Asia, and Australia. The study comprised three cohorts: 239 individuals at clinical high risk of psychosis (CHR-P), 328 patients who experienced a first episode of psychosis (FEP), and 139 healthy controls (HC). All participants were assessed at baseline. FEP participants were followed up at 2, 6, and 12 months. CHR-P participants were followed up at 3, 6, 12, 18, and 24 months. HC participants were followed up at 6 and 12 months.
Study design
Cohort - clinical
Number of participants at first data collection
328 (FEP participants)
239 (CHR-P participants)
139 (HC participants)
Age at first data collection
Varied (FEP participants)
Varied (CHR-P participants)
Varied (HC participants)
Participant year of birth
Varied (FEP participants)
Varied (CHR-P participants)
Varied (HC participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2016
Primary Institutions
Federal University of São Paulo (Universidade Federal de São Paulo, UNIFESP)
Centro de Investigación Biomédica en Red del área de Salud Mental (CIBERSAM)
King's College London (KCL)
Maastricht University Medical Center (Maastricht UMC+)
Queen Mary Hospital
Profile paper DOI
Funders
European Commission Seventh Framework Programme
Ongoing?
No
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Interview – online
- Interview – phone
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- None
- Diffusion Tensor Imaging (DTI)
- Functional magnetic resonance imaging (fMRI)
- Magnetic Resonance Imaging (MRI)
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
